[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":4057629.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1727687907.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1724875698.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-2774580.0,"NetIncomeLoss_1_Q2_USD":-106755145.0,"NetIncomeLoss_2_Q2_USD":-100993545.0,"OperatingIncomeLoss_1_Q2_USD":-5310980.0,"OperatingIncomeLoss_2_Q2_USD":-5606097.0,"PaymentsForUnderwritingExpense_2_Q2_USD":25875000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":155760.0,"PaymentsToAcquireRestrictedInvestments_2_Q2_USD":1725000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesCurrent_0_Q2_USD":4689267.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"PrepaidExpenseCurrent_0_Q2_USD":929250.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":1725000000.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":28875000.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":300000.0,"ProceedsFromSaleOfRestrictedInvestments_2_Q2_USD":124302.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-100998545.0,"SharePrice_0_Q2_USD":10.0,"StockholdersEquity_0_Q2_USD":5000009.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q2_USD":106755150.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":1466036200.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1725987976.0,"InvestmentIncomeInterest_2_Q2_USD":145339.0,"AdditionalPaidInCapital_0_Q2_USD":105991652.0,"Assets_0_Q2_USD":1725987976.0,"AssetsCurrent_0_Q2_USD":966879.0,"AssetsHeldInTrust_0_Q2_USD":37629.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":1725021097.0,"Cash_0_Q2_USD":37629.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":37629.0,"CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":37629.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"DueToRelatedPartiesCurrent_0_Q2_USD":631638.0,"Liabilities_0_Q2_USD":254951767.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":101545000.0,"GainLossOnSaleOfDerivatives_2_Q2_USD":9817500.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5310980.0,"GeneralAndAdministrativeExpense_2_Q2_USD":5606097.0,"IncomeLossFromContinuingOperations_1_Q2_USD":106855980.0,"IncomeLossFromContinuingOperations_2_Q2_USD":101138944.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-106755145.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-100993545.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":3429129.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":929250.0,"InvestmentIncomeInterest_1_Q2_USD":100835.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":92012500.0,"WarrantsAndRightsOutstanding_0_Q2_USD":189887500.0,"Ticker":"DNA","CIK":"1830214","name":"SOARING EAGLE ACQUISITION CORP.","OfficialName":"Ginkgo Bioworks Holdings Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"6721688334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NYSE","SP500":"nan","filed":"20210816"}]